Corteva (CTVA) Expected to Announce Earnings on Wednesday

Corteva (NYSE:CTVA - Get Free Report) is expected to post its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect Corteva to post earnings of $0.34 per share and revenue of $4.01 billion for the quarter. Parties that wish to register for the company's conference call can do so using this link.

Corteva Price Performance

NYSE:CTVA traded down $0.89 during trading hours on Friday, reaching $65.26. 3,750,069 shares of the company were exchanged, compared to its average volume of 2,672,879. The company has a current ratio of 1.50, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08. The firm has a market cap of $44.85 billion, a PE ratio of 65.92, a price-to-earnings-growth ratio of 1.70 and a beta of 0.77. Corteva has a twelve month low of $45.46 and a twelve month high of $66.24. The stock's 50-day moving average is $60.14 and its 200-day moving average is $57.89.

Corteva announced that its board has initiated a stock buyback program on Tuesday, November 19th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 7.5% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a dividend of $0.17 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.04%. Corteva's dividend payout ratio (DPR) is presently 68.69%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of research analyst reports. Citigroup increased their target price on Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a report on Wednesday. Barclays raised their price objective on Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a report on Tuesday, January 21st. UBS Group dropped their target price on shares of Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a report on Friday, January 10th. Oppenheimer reissued an "outperform" rating and issued a $70.00 price target (up from $69.00) on shares of Corteva in a research note on Friday, November 8th. Finally, Bank of America upped their price objective on shares of Corteva from $67.00 to $69.00 and gave the company a "buy" rating in a research note on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Corteva currently has an average rating of "Moderate Buy" and an average target price of $66.24.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.